Navigation Links
China Yingxia International Announces 2007 Third Quarter Financial Results Conference Call
Date:11/21/2007

-- Third Quarter Revenues Increase 89% to $3.51 Million versus $1.85

Million for Q3 of 2006 -- Third Quarter Net Income Before Taxes Increased 131% to $1.71 Million,

versus $0.74 Million for Q3 of 2006

NEW YORK, Nov. 21 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI), a leading provider in the nutraceutical industry engaged in the development, manufacture and distribution of organic nutritional food products, supplements, and personal care products in China, today announced that Ms. Yingxia Jiao, CEO and Chairwoman of China Yingxia, will host a conference call to discuss the Company's financial results for the third quarter ended September 30, 2007.

Net sales for the third quarter ended September 2007 totaled $3.51 million, an increase of 89% compared to $1.85 million for the third quarter of 2006. Cost of sales for the second quarter of 2007 was $0.90 million, yielding a gross profit of $2.61 million and a gross profit margin of 74%. Compared to the second quarter of 2006 cost of sales totaled $0.91 million and gross profit totaled $0.93 million yielding a gross profit of 50%.

Net income before taxes for the three months ended September 30, 2007 increased 131% to $1.71 million compared to $0.74 million for the three months ended September 30, 2007.

On the balance sheet, total assets for the third quarter of 2007 totaled $36.6 million, with reported total liabilities of $2.4 million.

''We were to pleased with the launch of our soybean product lines during the third quarter,'' stated Ms. Yingxia Jiao, CEO and Chairwoman of China Yingxia. ''We expect the soybean product line and the W3660 breed of rice aimed at diabetics and people suffering from kidney ailments to be our flagstaff products in the future quarters.''

Ms. Yingxia Jiao continued, ''I invite all our current investors and shareholders in addition to potential investors can join me on our third quarter conference call on Monday, November 26 at 9 a.m. to discuss the quarterly results in more detail and answer questions you may have.''

The conference call will take place at 9:00 a.m. Eastern, on Thursday, November 26, 2007. Anyone interested in participating should call 1-866-225- 8754 if calling within the United States, or 1-480-629-9564 if calling internationally, approximately 5 to 10 minutes prior to 9:00 a.m. There will be a playback available until December 3, 2007. To listen to the playback, please call 1-800-406-7325 if calling within the United States, or 1-303-590- 3030 if calling internationally. Please use pass code 3809920 for the replay.

This call is being webcast by ViaVid Broadcasting. The webcast may be accessed at ViaVid's Web site at http://viavid.net/dce.aspx?sid=000048C8 .

About China Yingxia International, Inc.

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ("Yingxia"), is primarily engaged in the development, production and sales of health food products in China. Yingxia is located in the Province of Heilongjiang in mainland China, and it currently has over 180 employees and 3 agricultural production bases. Yingxia's products include soybean-based foods and drinks, longgu golden millet enriched products, cactus-based herbal supplements, personal care products, Nestle products, and organic rice products.

CHINA YINGXIA INTERNATIONAL, INC.

CONDENSED CONSOLIDATED BALANCE SHEET (UNAUDITED)

SEPTEMBER 30, 2007

ASSETS

Current assets:

Cash and cash equivalents $ 1,501,901

Account receivables 440,448

Inventory 1,982,501

Other receivables 3,347,094

Advances to suppliers 4,254,468

Advance to affiliate 6,657,858

Loans to related party 1,432,218

Total Current Assets 19,616,487

Property and equipment, net of accumulated

depreciation of $2,996,681 16,675,349

Land use right, net 400,602

Total Assets $ 36,692,438

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable $ 1,622,516

Unearned revenue 3,337

Taxes payable 29,427

Accrued expenses and other payables 788,618

Total Current Liabilities 2,443,898

Total Liabilities 2,443,898

Stockholders' Equity

Preferred stock, $0.001 par value, 10,000,000

shares authorized; - 0 - shares outstanding

at September, 2007 --

Common stock, $0.001 par value, 100,000,000 shares

authorized; 44,333,987 shares outstanding at

September 30, 2007 44,334

Additional paid in capital 16,620,790

Accumulated other comprehensive income 1,933,256

Statutory reserves 901,463

Retained earnings 14,748,696

Total Shareholders' Equity 34,248,539

Total Liabilities and Stockholders' Equity $ 36,692,438

CHINA YINGXIA INTERNATIONAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(UNAUDITED)

Nine-Month Ended Three-Month Ended

September 30, September 30,

2007 2006 2007 2006

Sales $ 10,380,713 $5,308,352 3,513,674 $1,857,392

Cost of Sales 4,003,789 2,194,473 904,605 918,481

Gross Profit 6,376,924 3,113,879 2,609,069 938,911

Operating

Expenses

Research &

Development

Expense 279,286 -- 144,547 --

Selling,

general and

administrative 1,381,388 404,655 753,153 196,712

Operating

income 4,716,250 2,709,224 1,711,370 742,199

Other Income

and Expenses 2,898 (25,245) 2,412 52

Income Before

Income Taxes 4,719,148 2,683,979 1,713,782 742,251

(Benefit)

provision for

Income Taxes -- (1,984,590) -- (2,216,535)

Net Income $4,719,148 $4,668,569 $ 1,713,782 $2,958,786

Income per

common share

Basic $ 0.13 $ 0.41 $ 0.04 $ 0.26

Diluted $ 0.13 $ 0.41 $ 0.04 $ 0.26

Weighted average

common share

outstanding

Basic 35,866,849 11,418,877 40,309,204 11,418,877

Diluted 36,995,845 11,418,877 43,659,377 11,418,877

Safe Harbor Statement

The statements contained herein that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as "believes," "expects," "may," "will," "should," or "anticipates" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors discussed herein and expressed from time to time in our filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this filing, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

For more information, please contact:

Joe Levinson

Tel: +1-989-785-0208


'/>"/>
SOURCE China Yingxia International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... ... a year and a half of planning the Multiple Pathways of Recovery Conference , ... Recovery Conference was held May 2 -4, 2016 at the Mystic Marriott Hotel & ... explore the many pathways individuals use to get into and sustain their recovery. Pathways ...
(Date:5/27/2016)... NJ (PRWEB) , ... May 27, 2016 , ... Two ... named as YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The award ... their workplace. For this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services ...
(Date:5/27/2016)... ... May 27, 2016 , ... This campaign aims to ... which we as a society can control and change. , As nearly 795,000 Americans ... 40 seconds within the United States. Plus, with an estimated 129,000 of these people ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees ... stories, courtesy of leaders in the nursing and health care industry. It also ... advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is ...
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the ... for an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center ... Market Committee (FOMC) dot charts are of interest to the press for their noise ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... -- Diana Russell suffers from a form of rheumatoid arthritis ... This disease has put her in a wheelchair, and ... to leave her home.  Because of the size and ... wheelchair.  So if there is a family function, the ... to wait for the bus. Photo - ...
(Date:5/24/2016)... 24, 2016 Celsion Corporation (NASDAQ: ... today provided an update on its ongoing OVATION ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... is an IL-12 DNA plasmid vector formulated as ...
(Date:5/24/2016)... KONG , May 24, 2016 ... stent de doble terapia del mundo, introduce catéteres ... arteriovenosa. OrbusNeich, una compañía global especializada ... las vidas, ha expandido su cartera incluyendo productos ... balón JADE™ y Scoreflex™ PTA son los dispositivos ...
Breaking Medicine Technology: